Issuer Information

EDGAR: Contact Information
  • Name:
    Ensho Therapeutics, Inc.
  • Address:
    50 Tice Boulevard
    Suite 340 - #1005
    Woodcliff Lake, NEW JERSEY 07677
  • Phone:
    973-475-8970
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Within 5 years (2024)
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
584598: 0002032849-26-000001
First Sale: 2026-01-20
Security Type(s): Equity
Offer Amount: $20,000,000
Remaining: $20,000,000
06b

CA,

568053: 0002032849-25-000003
First Sale: 2025-06-12
Security Type(s): Debt
Offer Amount: $22,500,000
Amount Sold: $22,500,000
06b

NY,

537217: 0002032849-24-000002
First Sale: 2024-10-24
Security Type(s): Equity
Offer Amount: $12,500,000
Amount Sold: $5,000,000
Remaining: $7,500,000
06b

NY,

527938: 0002032849-24-000001
First Sale: 2024-07-19
Security Type(s): simple agreement for future equity.
Offer Amount: $2,000,000
Amount Sold: $400,000
Remaining: $1,600,000
06b

CA, MA, NJ, RI,

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.